Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
about
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptakeSystematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention.Temporal and geographical external validation study and extension of the Mayo Clinic prediction model to predict eGFR in the younger population of Swiss ADPKD patients.Individualised benefit-harm balance of aspirin as primary prevention measure - a good proof-of-concept, but could have been better….Effect of prestroke antiplatelets use on first-ever ischaemic stroke severity and early outcome.Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease.
P2860
Q26774593-999FAF73-2100-43BA-AAD9-F046B16CC4BFQ30241072-529DBB2B-F8BC-46CB-80AE-679E8680BE6AQ33910788-882CA527-3876-47D9-8E26-9A7A99CEE872Q36068944-8D0B4A7D-E42A-4431-8DBD-92558D9E9DE1Q40820113-414C3F67-1AC3-4833-97EC-DEF32E812E0DQ55278677-397211FD-A305-4069-AF8F-555F79CD5C78Q55383429-A3574E26-0B76-4933-A424-B274324D9BD0
P2860
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Benefit-harm analysis and char ...... diovascular disease and cancer
@ast
Benefit-harm analysis and char ...... diovascular disease and cancer
@en
type
label
Benefit-harm analysis and char ...... diovascular disease and cancer
@ast
Benefit-harm analysis and char ...... diovascular disease and cancer
@en
prefLabel
Benefit-harm analysis and char ...... diovascular disease and cancer
@ast
Benefit-harm analysis and char ...... diovascular disease and cancer
@en
P2093
P2860
P1433
P1476
Benefit-harm analysis and char ...... diovascular disease and cancer
@en
P2093
Cynthia M Boyd
Inge Stegeman
Milo A Puhan
Ravi Varadhan
P2860
P2888
P356
10.1186/S12916-015-0493-2
P407
P50
P577
2015-10-01T00:00:00Z
P5875
P6179
1010336206